These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35924923)

  • 1. Rotavirus VP4 Epitope of a Broadly Neutralizing Human Antibody Defined by Its Structure Bound with an Attenuated-Strain Virion.
    Jenni S; Li Z; Wang Y; Bessey T; Salgado EN; Schmidt AG; Greenberg HB; Jiang B; Harrison SC
    J Virol; 2022 Aug; 96(16):e0062722. PubMed ID: 35924923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to rotavirus outer capsid glycoprotein VP7 neutralize infectivity by inhibiting virion decapsidation.
    Ludert JE; Ruiz MC; Hidalgo C; Liprandi F
    J Virol; 2002 Jul; 76(13):6643-51. PubMed ID: 12050377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of membrane permeabilization and receptor binding sites on the VP4 hemagglutinin of rotavirus: implications for cell entry.
    Tihova M; Dryden KA; Bellamy AR; Greenberg HB; Yeager M
    J Mol Biol; 2001 Dec; 314(5):985-92. PubMed ID: 11743716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual Recognition of Sialic Acid and αGal Epitopes by the VP8* Domains of the Bovine Rotavirus G6P[5] WC3 and of Its Mono-reassortant G4P[5] RotaTeq Vaccine Strains.
    Alfajaro MM; Kim JY; Barbé L; Cho EH; Park JG; Soliman M; Baek YB; Kang MI; Kim SH; Kim GJ; Park SI; Pendu JL; Cho KO
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31243129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolysis of monomeric recombinant rotavirus VP4 yields an oligomeric VP5* core.
    Dormitzer PR; Greenberg HB; Harrison SC
    J Virol; 2001 Aug; 75(16):7339-50. PubMed ID: 11462006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site.
    Dormitzer PR; Sun ZY; Wagner G; Harrison SC
    EMBO J; 2002 Mar; 21(5):885-97. PubMed ID: 11867517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and characterization of a novel truncated rotavirus VP4 for the development of a recombinant rotavirus vaccine.
    Li Y; Xue M; Yu L; Luo G; Yang H; Jia L; Zeng Y; Li T; Ge S; Xia N
    Vaccine; 2018 Apr; 36(16):2086-2092. PubMed ID: 29555220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The VP5 domain of VP4 can mediate attachment of rotaviruses to cells.
    Zárate S; Espinosa R; Romero P; Méndez E; Arias CF; López S
    J Virol; 2000 Jan; 74(2):593-9. PubMed ID: 10623720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional refolding of the penetration protein on a non-enveloped virus.
    Herrmann T; Torres R; Salgado EN; Berciu C; Stoddard D; Nicastro D; Jenni S; Harrison SC
    Nature; 2021 Feb; 590(7847):666-670. PubMed ID: 33442061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VP5* rearranges when rotavirus uncoats.
    Yoder JD; Trask SD; Vo TP; Binka M; Feng N; Harrison SC; Greenberg HB; Dormitzer PR
    J Virol; 2009 Nov; 83(21):11372-7. PubMed ID: 19692464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity, antigenicity, and protection efficacy of baculovirus expressed VP4 trypsin cleavage products, VP5(1)* and VP8* from rhesus rotavirus.
    Dunn SJ; Fiore L; Werner RL; Cross TL; Broome RL; Ruggeri FM; Greenberg HB
    Arch Virol; 1995; 140(11):1969-78. PubMed ID: 7503695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of rotavirus outer-layer protein VP7 bound with a neutralizing Fab.
    Aoki ST; Settembre EC; Trask SD; Greenberg HB; Harrison SC; Dormitzer PR
    Science; 2009 Jun; 324(5933):1444-7. PubMed ID: 19520960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of VP4 neutralization sites in rotavirus by three-dimensional cryo-electron microscopy.
    Prasad BV; Burns JW; Marietta E; Estes MK; Chiu W
    Nature; 1990 Feb; 343(6257):476-9. PubMed ID: 2153941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterotypic protection and induction of a broad heterotypic neutralization response by rotavirus-like particles.
    Crawford SE; Estes MK; Ciarlet M; Barone C; O'Neal CM; Cohen J; Conner ME
    J Virol; 1999 Jun; 73(6):4813-22. PubMed ID: 10233942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atomic model of an infectious rotavirus particle.
    Settembre EC; Chen JZ; Dormitzer PR; Grigorieff N; Harrison SC
    EMBO J; 2011 Jan; 30(2):408-16. PubMed ID: 21157433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-induced conformational change of the rotavirus VP4 spike: implications for cell entry and antibody neutralization.
    Pesavento JB; Crawford SE; Roberts E; Estes MK; Prasad BV
    J Virol; 2005 Jul; 79(13):8572-80. PubMed ID: 15956598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral immune responses to VP4 and its cleavage products VP5* and VP8* in infants vaccinated with rhesus rotavirus.
    Padilla-Noriega L; Fiore L; Rennels MB; Losonsky GA; Mackow ER; Greenberg HB
    J Clin Microbiol; 1992 Jun; 30(6):1392-7. PubMed ID: 1320626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture.
    Ruggeri FM; Greenberg HB
    J Virol; 1991 May; 65(5):2211-9. PubMed ID: 1850007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial Passaging of the Human Rotavirus CDC-9 Strain in Cell Culture Leads to Attenuation: Characterization from
    Resch TK; Wang Y; Moon S; Jiang B
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32461318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Location of intrachain disulfide bonds in the VP5* and VP8* trypsin cleavage fragments of the rhesus rotavirus spike protein VP4.
    Patton JT; Hua J; Mansell EA
    J Virol; 1993 Aug; 67(8):4848-55. PubMed ID: 8392619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.